Mylan dura

Mylan dura, now operating as part of Viatris following the 2020 merger of Mylan and Pfizer's Upjohn division, is a major pharmaceutical entity based in Germany. The company specializes in the development, manufacturing, and distribution of a vast portfolio of generic and specialty medicines across numerous therapeutic areas, including cardiovascular, respiratory, and metabolic diseases. As a key regional subsidiary, it provides high-quality affordable healthcare solutions, including complex generics and biosimilars, to the European market. The organization leverages a global supply chain to ensure patient access to critical treatments ranging from oral solids to injectable therapies.